Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Bioorg Med Chem. 2013 Jan 9;21(5):1123–1135. doi: 10.1016/j.bmc.2012.12.043

Table 2.

Extent of HASMC proliferation inhibition exhibited by NO-donors with and without ABH (5 mM)

A6' B6' ABH
Concentration: 20
µM
20
µM
5 mM
%Viability Reduction: 28
Without ABH (Rwo) 23 18 --
Sum reduction (Rwo + RABH) 51 46 --
With ABH (Rw) 64 48 --
Rw − (Rwo + RABH) 13 2 --